삼성서울병원

Ko En

Lee, Jeeyun M.D

TITLE
Associate Professor, Division of Hem/Oncology, Samsung Medical Center
Treament Schedule 01 月
DATE
SAT
01
SUN
02
MON
03
TUE
04
WEB
05
THU
06
FRI
07
SAT
08
SUN
09
MON
10
TUE
11
WEB
12
THU
13
FRI
14
SAT
15
SUN
16
MON
17
TUE
18
WEB
19
THU
20
FRI
21
SAT
22
SUN
23
MON
24
TUE
25
WEB
26
THU
27
FRI
28
SAT
29
SUN
30
MON
31
AM
PM
Treament Schedule 02 月
DATE
TUE
01
WEB
02
THU
03
FRI
04
SAT
05
SUN
06
MON
07
TUE
08
WEB
09
THU
10
FRI
11
SAT
12
SUN
13
MON
14
TUE
15
WEB
16
THU
17
FRI
18
SAT
19
SUN
20
MON
21
TUE
22
WEB
23
THU
24
FRI
25
SAT
26
SUN
27
MON
28
AM
PM

Medical School

School of Medicine, Ewha University, Seoul, Korea

Specialty Training

Fellowship   Clinical Fellowship in Hematology-Oncology, Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
Residency   Residency in Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
Internship   Internship, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

Other Education

2006.7 ~ 2007.12 Visiting Scientist, Sidney Kimmel Cancer Center, USA

Clinical & Research Interests

gastric cancer, colorectal cancer, sarcoma, melanoma, others

Participation in Academic Societies
and Research

American Society of Clinical Oncology
AACR
Korean Association of Clinical Oncology

Selected Publications

  • EUR RADIOL 2021 10.1007/s00330-021-08094-3 Prediction of epithelial-to-mesenchymal transition molecular subtype using CT in gastric cancer Cha1, DI; Lee, J; Jeong, WK; Kim, ST; Kim, JH; Hong, JY; Kang, WK; Kim, KM; Kim, SW; Choi, D
    View PubMed
  • NATURE 2021 10.1038/s41586-021-03515-1 ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma Yen1, I; Shanahan, F; Lee, J; Hong, YS; Shin, SJ; Moore, AR; Sudhamsu, J; Chang, MT; Bae, I; Dela Cruz, D; Hunsaker, T; Klijn, C; Liau, NPD; Lin, E; Martin, SE; Modrusan, Z; Piskol, R; Segal, E; Venkatanarayan, A; Ye, X; Yin, JP; Zhang, LX; Kim, JS; Lim, HS; Kim, KP; Kim, YJ; Han, HS; Lee, SJ; Kim, ST; Jung, M; Hong, YH; Noh, YS; Choi, M; Han, O; Nowicka, M; Srinivasan, S; Yan, YB; Kim, TW; Malek, S
    View PubMed
  • CANCERS 2021 10.3390/cancers13102316 Validation of the Combined Biomarker for Prediction of Response to Checkpoint Inhibitor in Patients with Advanced Cancer Kim1, JC; Heo, YJ; Kang, SY; Lee, J; Kim, KM
    View PubMed
  • JAMA ONCOL 2021 10.1001/jamaoncol.2021.0275 Assessment of Pembrolizumab Therapy for the Treatment of Microsatellite Instability-High Gastric or Gastroesophageal Junction Cancer Among Patients in the KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 Clinical Trials Chao1, JS; Fuchs, CS; Shitara, K; Tabernero, J; Muro, K; Van Cutsem, E; Bang, YJ; De Vita, F; Landers, G; Yen, CJ; Chau, I; Elme, A; Lee, J; Ozguroglu, M; Catenacci, D; Yoon, HH; Chen, ER; Adelberg, D; Shih, CS; Shah, SK; Bhagia, P; Wainberg, ZA
    View PubMed
  • J DERMATOL 2021 10.1111/1346-8138.15824 Clinical profile of cutaneous adverse events of immune checkpoint inhibitors in a single tertiary center Park1, JH; Yoon, D; Lee, J; Oh, SJ; Kim, HJ; Lee, JH; Lee, DY
    View PubMed